.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The NATHEALTH healthcare leadership is entering a transformative new era for the fiscal year 2026–27. As the apex body representing the Indian healthcare industry, NATHEALTH recently announced strategic expansions to its governing team. Shankha Banerjee, CEO of Dr. Lal PathLabs, has taken the role of Treasurer. Meanwhile, Mandeep Singh Kumar, Managing Director and Vice President of Medtronic India, joins as Secretary. These appointments followed a significant Governing Council meeting aimed at strengthening the organization’s strategic influence. Consequently, the leadership expansion reflects a commitment to integrating diagnostics and medical technology into the core of India's health policy.
Sangita Reddy, Joint Managing Director of Apollo Hospitals, continues to lead the organization as President. The current leadership roster also includes Himanshu Baid as Senior Vice President and Varun Khanna as Vice President. This diverse group of experts brings a comprehensive understanding of the care continuum to the table. Furthermore, Siddhartha Bhattacharya will continue his role as Secretary General. He will focus on expanding regional stakeholder engagement and collaborating with policymakers. Therefore, the organization is well-positioned to drive systemic change across the entire healthcare ecosystem. These efforts align closely with the national vision of Viksit Bharat 2047, focusing on long-term patient wellbeing and safety.
Shankha Banerjee emphasized the growing importance of early intervention during his appointment remarks. He noted that data-driven decision-making is essential for addressing the rising burden of non-communicable diseases in India. Additionally, diagnostics will play a critical role in enabling early detection and guiding clinical decisions. Mandeep Singh Kumar highlighted that India’s healthcare ecosystem is currently at a pivotal moment. Evolving patient expectations and rapid innovation are driving significant shifts in care delivery. Consequently, fostering collaboration across the government and private industry remains a top priority. The team intends to build a future-ready healthcare system through enhanced public-private partnerships and improved clinical outcomes.
Q1: Who are the new appointees in the NATHEALTH leadership team?
Shankha Banerjee from Dr. Lal PathLabs was appointed as Treasurer, and Mandeep Singh Kumar from Medtronic India was appointed as Secretary for the 2026–27 term.
Q2: What is the primary objective of the expanded NATHEALTH team?
The team aims to drive systemic change in the healthcare ecosystem by focusing on diagnostics, medical technology, and preventive healthcare to support India's 2047 development goals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NATHEALTH appoints Shankha Banerjee and Mandeep Singh Kumar to its FY 2026-27 leadership team to drive diagnostic and medical technology innovation in India...
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
